NovelMed Therapeutics' Grant

NovelMed Therapeutics raised a round of funding on September 12, 2013. Investors include National Institutes of Health.

NovelMed Therapeutics is a privately-held biotech company developing transformative treatments for orphan and non-orphan disease conditions. The company has developed a portfolio of antibodies targete…

Articles about NovelMed Therapeutics' Grant: